Education and experience:
Dr Helga Gardarsdottir is an associate professor at the Division of Pharmacoepidemiology & Clinical Pharmacology. She was trained as a pharmacist at Uppsala University in Sweden and worked for two years at the International Pharmaceutical Federation (FIP) in The Hague following her graduation. Helga obtained her PhD in pharmacoepidemiology from Utrecht University in 2009 with a thesis entitled “Drug treatment episodes in pharmacoepidemiology: Antidepressants as a model”. Between 2009 and 2017 she worked as a post-doc and later as assistant professor at the department of Clinical Pharmacy at University Medical Center Utrecht.
Her primary research interests include the application and development of innovative approaches to generate and analyse real world data on safety and effectiveness of medicines to inform regulatory and clinical decision making. Special research interest is on assessing impact of drug regulation on safe and effective use in populations. Dr Gardarsdottir was trained as a pharmacist and a pharmacoepidemiologist. She is a winner of a personal VENI prize from the Netherlands Organisation for Scientific Research (NWO) and has led and participated in a number of international multi-country research projects including the IMI-PROTECT project and the IMI Trials@home project. She is a member of the ENCePP working group responsible for the “Guide on Methodologal Standards in Pharmacoepidemiology“ and the SIG on Measuring Impact of Pharmacovigilance Activities. Furthermore, she is the co-lead for the Real-World Evidence Task Force of the International Society of Pharmacoepidemiology and associate editor of the journal ‘Pharmacoepidemiology & Drug Safety’.